Abstract
Recent experimental studies have found that photodynamic therapy (PDT) combined with programmed death receptor 1 (PD-1)/programmed cell death-Ligand 1 (PD-L1) inhibitors can effectively inhibit in situ tumor growth and prevent tumor recurrence and metastasis, and has emerged as a new therapeutic option. However, clinical data is still limited.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献